{"title":"Transient anticholinergic burden and out-of-hospital cardiac arrest: a case-crossover study.","authors":"Ming-Jen Tsai,Chris Tzu-Ting Su,Sheng-Feng Sung,Hsin-Yi Yang,Michael Chun-Yuan Cheng,Albert Tzu-Ming Chuang,Shih-Chieh Shao,Edward Chia-Cheng Lai","doi":"10.1093/eurheartj/ehaf723","DOIUrl":null,"url":null,"abstract":"BACKGROUND AND AIMS\r\nAnticholinergic burden has been linked to cardiovascular events and mortality, but its association with out-of-hospital cardiac arrest (OHCA) remains unclear. This study investigated whether transient increases in anticholinergic burden elevate OHCA risk in middle-aged and older populations.\r\n\r\nMETHODS\r\nA nationwide case-crossover, case-time-control, and case-case-time-control study using Taiwan's National Health Insurance Research Database involved 173 974 adults aged ≥40 years who experienced OHCA between 2011 and 2021. The participants were middle-aged (40-64 years) or older (≥65 years). Anticholinergic burden was assessed using established scales and categorized as 0, 1-2, and 3 or more points. Each participant's burden during the hazard period (days -30 to -1 before OHCA) was compared to a randomly selected 30-day reference period (from days -180 to -61). Conditional logistic regression was used to estimate odds ratios (ORs) with 95% confidence intervals (CIs).\r\n\r\nRESULTS\r\nCase-crossover analysis showed more patients having higher anticholinergic burden during the hazard period than during the reference period in both age groups. The ORs for OHCA were 1.48 (95% CI: 1.42-1.55) and 1.56 (95% CI: 1.52-1.61) for scores of 1-2, compared with 0, and 2.03 (95% CI: 1.95-2.11) and 2.21 (95% CI: 2.15-2.27) for scores of 3 or more, compared to 0, in the middle-aged and older groups, respectively. Case-time-control and case-case-time-control analyses consistently showed a dose-response relationship, with results confirmed by sensitivity analyses.\r\n\r\nCONCLUSIONS\r\nTransient increases in anticholinergic burden significantly raise OHCA risk, particularly among individuals with higher burden levels.","PeriodicalId":11976,"journal":{"name":"European Heart Journal","volume":"94 1","pages":""},"PeriodicalIF":35.6000,"publicationDate":"2025-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Heart Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/eurheartj/ehaf723","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
BACKGROUND AND AIMS
Anticholinergic burden has been linked to cardiovascular events and mortality, but its association with out-of-hospital cardiac arrest (OHCA) remains unclear. This study investigated whether transient increases in anticholinergic burden elevate OHCA risk in middle-aged and older populations.
METHODS
A nationwide case-crossover, case-time-control, and case-case-time-control study using Taiwan's National Health Insurance Research Database involved 173 974 adults aged ≥40 years who experienced OHCA between 2011 and 2021. The participants were middle-aged (40-64 years) or older (≥65 years). Anticholinergic burden was assessed using established scales and categorized as 0, 1-2, and 3 or more points. Each participant's burden during the hazard period (days -30 to -1 before OHCA) was compared to a randomly selected 30-day reference period (from days -180 to -61). Conditional logistic regression was used to estimate odds ratios (ORs) with 95% confidence intervals (CIs).
RESULTS
Case-crossover analysis showed more patients having higher anticholinergic burden during the hazard period than during the reference period in both age groups. The ORs for OHCA were 1.48 (95% CI: 1.42-1.55) and 1.56 (95% CI: 1.52-1.61) for scores of 1-2, compared with 0, and 2.03 (95% CI: 1.95-2.11) and 2.21 (95% CI: 2.15-2.27) for scores of 3 or more, compared to 0, in the middle-aged and older groups, respectively. Case-time-control and case-case-time-control analyses consistently showed a dose-response relationship, with results confirmed by sensitivity analyses.
CONCLUSIONS
Transient increases in anticholinergic burden significantly raise OHCA risk, particularly among individuals with higher burden levels.
期刊介绍:
The European Heart Journal is a renowned international journal that focuses on cardiovascular medicine. It is published weekly and is the official journal of the European Society of Cardiology. This peer-reviewed journal is committed to publishing high-quality clinical and scientific material pertaining to all aspects of cardiovascular medicine. It covers a diverse range of topics including research findings, technical evaluations, and reviews. Moreover, the journal serves as a platform for the exchange of information and discussions on various aspects of cardiovascular medicine, including educational matters.
In addition to original papers on cardiovascular medicine and surgery, the European Heart Journal also presents reviews, clinical perspectives, ESC Guidelines, and editorial articles that highlight recent advancements in cardiology. Additionally, the journal actively encourages readers to share their thoughts and opinions through correspondence.